Home/Filings/4/0001368993-17-000026
4//SEC Filing

WaferGen Bio-systems, Inc. 4

Accession 0001368993-17-000026

CIK 0001368993operating

Filed

Feb 28, 7:00 PM ET

Accepted

Mar 1, 2:29 PM ET

Size

5.6 KB

Accession

0001368993-17-000026

Insider Transaction Report

Form 4
Period: 2017-02-28
TRIFUNOVICH IVAN
DirectorPresident and CEO
Transactions
  • Disposition to Issuer

    Stock Option (right to buy)

    2017-02-2858,4690 total
    Exercise: $2.80Exp: 2023-01-22Common Stock (58,469 underlying)
Footnotes (1)
  • [F1]Pursuant to the Agreement and Plan of Merger, dated May 12, 2016, by and among WaferGen Bio-systems, Inc., Takara Bio USA Holdings, Inc., Walrus Acquisition Corporation and Takara Bio USA, Inc., this option, which was fully vested as of the closing of the merger, was cancelled in exchange for a cash payment for each share subject to the option equal to the excess of $7.347126 over the per share exercise price of the option.

Issuer

WaferGen Bio-systems, Inc.

CIK 0001368993

Entity typeoperating
IncorporatedNV

Related Parties

1
  • filerCIK 0001368993

Filing Metadata

Form type
4
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 2:29 PM ET
Size
5.6 KB